血庫設備市場：血液採集設備、血液處理設備、血液儲存設備（按地區分類），2026 年至 2032 年

血庫設備市場評估-2026-2032

癌症和貧血等疾病的增多使得輸血成為必要，從而推動了血庫設備的普及。人口老化將導致對血液製品和血庫服務的需求增加，預計市場規模將在2024年超過452.8億美元，到2032年將達到約848億美元的估值。

除此之外，血液儲存和保存技術的創新使血庫流程更加高效和安全。由於外科手術數量不斷增加，包括複雜手術和緊急手術，預計市場在 2026 年至 2032 年期間的複合年成長率將達到 9.00%。

血庫設備市場定義/概述

血庫設備是用於血液及血液成分的採集、處理、檢測、儲存和分配的專用醫療設備。這些設備確保血液的安全處理和儲存，以維持其在輸血和其他醫療用途的有效性。主要設備包括採血袋、冰箱和冷凍庫、血液混合器、離心機、血庫分析儀等。

血庫設備主要用於血庫、醫院、診斷中心和實驗室。它們在採集捐血者血液、分離和儲存紅血球、血漿和血小板等各種血液成分以及傳染病檢查以確保血液安全方面發揮著至關重要的作用。這些設備還支援血漿置換和自體輸血等治療程序，並且在各種醫療狀況、手術和緊急情況下對患者護理至關重要。

科技進步將如何促進血庫設備的採用？

由於各種醫療程序對血液和血液成分的需求不斷成長，血庫設備市場正在經歷顯著成長。慢性病盛行率上升、外科手術增多、血液採集和儲存技術的進步等因素正在刺激市場擴張。根據世界衛生組織 (WHO) 統計，2018 年全球捐血量達 1.185 億次，血庫業務規模之大可見一斑。Terumo Corporation)宣布將於 2024 年 4 月推出一款新型自動血液成分分離機，以提高血液處理效率，促進市場擴張。

血庫設備的技術進步是主要驅動力，創新重點在於提高血液採集、處理和儲存的安全性、效率和自動化程度。這些發展對於滿足日益成長的需求並確保血液製品的品質和安全至關重要。美國食品藥物管理局報告稱，2019年美國採集了超過1,360萬單位的全血和紅血球。 2024年1月，Haemonetics公司推出了一個用於血液中心管理的全新軟體平台，旨在簡化業務並增強血庫流程的可追溯性。

血液疾病盛行率的上升和創傷病例的增加也推動了血庫設備的需求。隨著世界各地的醫療保健系統努力提高緊急準備能力，人們越來越關注如何維持充足的血液供應。根據美國紅十字會統計，在美國，每兩秒鐘就有一人需要輸血，因此對高效率的血庫系統的需求持續成長。 2024年3月，費森尤斯卡比推出了一項新的血小板病原體去活化技術，解決了輸血傳染感染疾病的擔憂，並有可能擴大血庫設備市場。

網路安全和血庫設備的成本是否會限制其採用？

血庫設備市場的主要限制因素之一是先進血庫設備和技術的高成本。許多醫院和血庫機構，尤其是在開發中國家，都面臨預算限制，這限制了它們投資最新設備的能力。高昂的初始購買、維護和營運成本可能會阻礙小型醫療機構採用這些技術，從而抑制市場成長。

另一個重大挑戰是血庫設備法規環境的嚴格。確保符合FDA和EMA等衛生當局製定的眾多法規和標準需要投入大量的時間和資金。為了保持合規性而不斷更新和審核，可能會給製造商和醫療保健提供者帶來負擔，並減緩市場對新技術和創新的採用。

民眾和醫護人員對捐血和先進血庫設備技術重要性的認知和教育不足也是一個挑戰。在許多地區，醫護人員缺乏使用先進血庫設備的培訓，導致這些技術未能充分利用。此外，對捐血的誤解和恐懼阻礙了捐血者的招募，導致血液供應不足，影響了血庫業務的有效性。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

第4章 血庫設備市場（按採血設備）

• 針頭和注射器
• 血袋
• 採血管

5. 血庫設備市場（依血液處理設備）

• 離心機
• 過濾器
• 血液分析儀

6. 血庫設備市場類型

• 冰箱和冷凍庫
• 血庫冰箱

第7章 血庫設備市場（依血液儲存設備）

• 冰箱和冷凍庫
• 血庫冰箱

第8章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第9章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第10章 競爭格局

• 主要企業
• 市場佔有率分析

第11章 公司簡介

• Terumo Corporation
• Fresenius Kabi
• Haemonetics Corporation
• Grifols SA
• Macopharma
• Becton, Dickinson and Company（BD）
• Beckman Coulter, Inc.（Danaher Corporation）
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Immucor, Inc.
• Ortho Clinical Diagnostics
• Sartorius AG
• Siemens Healthineers AG
• Mediware Information Systems, Inc.
• Cerus Corporation
• LivaNova PLC
• MacoPharma SA
• Kawasumi Laboratories, Inc.
• China Biologic Products Holdings, Inc.

第12章 市場展望市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第13章 附錄

• 簡稱列表
• 來源和參考文獻

Blood Banking Devices Market Valuation - 2026-2032

Increased incidences of diseases like cancer and anemia necessitate frequent blood transfusions is propelling the adoption of blood banking devices. An aging population leads to higher demand for blood products and blood banking services is driving the market size surpass USD 45.28 Billion valued in 2024 to reach a valuation of around USD 84.8 Billion by 2032.

In addition to this, innovations in blood storage and preservation technologies enhance the efficiency and safety of blood banking processes. The increasing number of surgeries, including complex and emergency procedures are enabling the market to grow at a CAGR of 9.00% from 2026 to 2032.

Blood Banking Devices Market: Definition/ Overview

Blood banking devices are specialized medical equipment used for the collection, processing, testing, storage, and distribution of blood and blood components. These devices ensure the safe handling and preservation of blood to maintain its viability for transfusions and other medical purposes. Key devices include blood collection bags, refrigerators and freezers, blood mixers, centrifuges, and blood bank analyzers.

Blood banking devices are primarily used in blood banks, hospitals, diagnostic centers, and research laboratories. They play a critical role in blood collection from donors, separating and storing different blood components like red cells, plasma, and platelets, and testing for infectious diseases to ensure blood safety. These devices also support therapeutic procedures such as plasma exchange and autologous blood transfusion, which are vital for patient care in various medical conditions, surgeries, and emergencies.

How will Technological Advancements Increase Adoption of Blood Banking Devices?

The blood banking devices market is experiencing significant growth, driven by increasing demand for blood and blood components in various medical procedures. Factors such as rising incidence of chronic diseases, growing number of surgical procedures, and advancements in blood collection and storage technologies are fueling market expansion. According to the World Health Organization, 118.5 million blood donations were collected globally in 2018, highlighting the scale of blood banking operations. In April 2024, Terumo Corporation announced the launch of its new automated blood component separator, enhancing efficiency in blood processing and contributing to market growth.

Technological advancements in blood banking devices are a major driver, with innovations focusing on improving safety, efficiency, and automation in blood collection, processing, and storage. These developments are crucial in meeting the growing demand for blood products while ensuring their quality and safety. The U.S. Food and Drug Administration reported that over 13.6 million units of whole blood and red blood cells were collected in the United States in 2019. In January 2024, Haemonetics Corporation introduced a new software platform for blood center management, streamlining operations and enhancing traceability in blood banking processes.

The increasing prevalence of blood disorders and the rising number of trauma cases are also driving the demand for blood banking devices. As healthcare systems worldwide strive to improve emergency preparedness, there's a growing focus on maintaining adequate blood supplies. According to the American Red Cross, someone in the U.S. needs blood every two seconds, underscoring the constant need for efficient blood banking systems. In March 2024, Fresenius Kabi unveiled a new pathogen reduction technology for platelets, addressing concerns about transfusion-transmitted infections and potentially expanding the market for blood banking devices.

Will Cybersecurity and Costs of Blood Banking Devices Restrain Its Application?

One of the primary restraints of the blood banking devices market is the high cost associated with advanced blood banking equipment and technologies. Many hospitals and blood banks, especially in developing countries, face budget constraints that limit their ability to invest in the latest devices. The initial purchase, maintenance, and operational costs can be prohibitive, preventing smaller healthcare facilities from adopting these technologies and thereby restricting market growth.

Another significant challenge is the stringent regulatory environment surrounding blood banking devices. Ensuring compliance with numerous regulations and standards imposed by health authorities like the FDA and EMA requires considerable time and financial investment. The need for continuous updates and audits to maintain regulatory compliance can be burdensome for manufacturers and healthcare providers, potentially slowing the adoption of new technologies and innovations in the market.

Limited awareness and education about the importance of blood donation and advanced blood banking technologies among the general public and healthcare professionals also pose a challenge. In many regions, there is a lack of adequate training for healthcare workers on the use of sophisticated blood banking devices, leading to suboptimal utilization of these technologies. Additionally, misconceptions and fears about blood donation can hinder donor recruitment efforts, resulting in insufficient blood supply and impacting the effectiveness of blood banking operations.

Category-Wise Acumens

Will Rise in Adoption of Centrifuges Drive Blood Banking Devices Market?

Centrifuges are dominating the blood banking devices market, playing a crucial role in the separation and processing of blood components. These devices are essential for isolating platelets, plasma, and red blood cells from whole blood, enabling efficient storage and targeted transfusion therapies. The increasing demand for blood components in various medical procedures, coupled with advancements in centrifuge technology, is driving market growth. According to the World Health Organization, over 117.4 million blood donations are collected globally each year, with a significant portion processed using centrifuges. In February 2024, Thermo Fisher Scientific launched a new high-capacity blood bank centrifuge, capable of processing up to 12 units of whole blood simultaneously.

The efficiency and reliability of centrifuges in blood component separation have made them indispensable in blood banks and transfusion centers. Modern centrifuges offer features such as automated balancing, temperature control, and programmable protocols, enhancing the quality and consistency of blood components. The U.S. Food and Drug Administration reported that in 2020, approximately 10.2 million units of whole blood were collected in the United States, with most undergoing centrifugation for component separation. In April 2024, Beckman Coulter announced the integration of artificial intelligence into their latest blood bank centrifuge, optimizing separation parameters based on individual sample characteristics.

Centrifuges are also playing a vital role in addressing global health challenges, including the management of blood supplies during pandemics and natural disasters. The ability to quickly process large volumes of blood donations is critical in emergency situations. According to the American Red Cross, every two seconds someone in the U.S. needs blood, emphasizing the constant need for efficient blood processing. In January 2024, Haemonetics Corporation introduced a new centrifuge designed specifically for small and mobile blood collection centers, improving access to blood banking capabilities in remote areas and during emergencies.

Will Rise in Adoption of Blood Collection Tubes Drive Blood Banking Devices Market?

Blood collection tubes are emerging as a dominant force in the blood banking devices market, playing a crucial role in the safe and efficient collection, storage, and transportation of blood samples. These tubes, available in various types with specific additives, ensure the integrity of blood samples for accurate testing and processing. The increasing demand for blood diagnostics, coupled with the rise in chronic diseases and surgical procedures, is driving the growth of blood collection tubes. According to the Centers for Disease Control and Prevention (CDC), over 7 billion clinical lab tests are performed annually in the United States, with a significant portion involving blood samples. In March 2024, BD (Becton, Dickinson and Company) launched a new line of eco-friendly blood collection tubes, addressing sustainability concerns in healthcare.

The advancements in blood collection tube technology have significantly improved sample quality and reduced contamination risks, making them indispensable in modern blood banking. These tubes now feature innovations such as improved additive formulations, enhanced barrier gels, and specialized coatings to maintain sample stability. The World Health Organization reported that in 2020, approximately 118 million blood donations were collected globally, highlighting the massive scale of blood collection tube usage. In January 2024, Greiner Bio-One International GmbH introduced a new vacuum blood collection tube with extended stability for rare blood type samples, addressing a critical need in specialized blood banking.

Country/Region-wise Acumens

Will Advanced Healthcare Infrastructure in North America Drive Blood Banking Devices Market Growth?

North America is dominating the blood banking devices market owing to advanced healthcare infrastructure, high adoption rates of new technologies, and a well-established blood donation system. The region's robust research and development activities in blood banking technologies contribute significantly to market growth. According to the American Red Cross, approximately 36,000 units of red blood cells are needed every day in the United States, underlining the constant demand for efficient blood banking devices. In February 2024, Abbott Laboratories launched a new automated blood and plasma screening system in the U.S., enhancing the efficiency and safety of blood testing processes.

The presence of major market players and supportive government initiatives further strengthen North America's position in the blood banking devices market. These factors have led to the development and implementation of cutting-edge technologies in blood collection, processing, and storage. The U.S. Food and Drug Administration reported that in 2022, over 15.7 million units of whole blood and red blood cells were collected in the country, highlighting the scale of blood banking operations. In April 2024, Terumo BCT announced the expansion of its manufacturing facility in Colorado, aiming to increase production capacity for blood component collection and processing systems.

Will Rising Demand for Blood and Blood Components Enhance Adoption of Blood Banking Devices in Asia Pacific?

The Asia Pacific blood banking devices market is experiencing rapid growth, driven by increasing demand for blood and blood components in healthcare settings. According to the World Health Organization, the region collected approximately 83 million blood donations in 2021, representing a 10% increase from 2018. This growth is attributed to rising healthcare expenditure, improving healthcare infrastructure, and a growing awareness of blood donation. Key players like Terumo Corporation and Haemonetics Corporation have been expanding their presence in the region to capitalize on this growth.

Technological advancements in blood banking devices are further propelling market growth. The Indian Council of Medical Research reported that the adoption of automated blood component separators increased by 35% between 2019 and 2024 in India alone. In February 2024, Japanese company Sysmex Corporation launched its new XN-31 automated hematology analyzer in Southeast Asian markets, offering improved efficiency in blood cell analysis. This innovation highlights the industry's focus on enhancing blood testing accuracy and efficiency to meet the growing demand for blood products.

Competitive Landscape

The blood banking devices market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the blood banking devices market include:

• Terumo Corporation
• Fresenius Kabi
• Haemonetics Corporation
• Grifols S.A.
• Macopharma
• Becton, Dickinson and Company (BD)
• Beckman Coulter, Inc. (Danaher Corporation)
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Immucor, Inc.
• Ortho Clinical Diagnostics
• Sartorius AG
• Siemens Healthineers AG
• Mediware Information Systems, Inc.
• Cerus Corporation
• LivaNova PLC
• MacoPharma SA
• Kawasumi Laboratories, Inc.
• China Biologic Products Holdings, Inc.

Latest Developments

• In September 2024, Terumo Blood and Cell Technologies launched a new automated blood collection system that features enhanced user interface and advanced blood processing capabilities for increased efficiency.
• In August 2024, Haemonetics Corporation introduced a state-of-the-art blood centrifuge with improved separation technology, offering higher yield and better quality of blood components.

Blood Banking Devices Market, By Category

• Blood Collection Devices:
• Needles and Syringe
• Blood Bags
• Blood Collection Tubes
• Blood Processing Devices:
• Centrifuges
• Filters
• Hematology Analyzers
• Blood Storage Devices:
• Refrigerators and Freezers
• Blood Bank Refrigerators
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Blood Banking Devices Market, By Blood Collection Devices

• Needles and Syringes
• Blood Bags
• Blood Collection Tubes

5. Blood Banking Devices Market, By Blood Processing Devices

• Centrifuges
• Filters
• Hematology Analyzers

6. Blood Banking Devices Market, By Type

• Refrigerators and Freezers
• Blood Bank Refrigerators

7. Blood Banking Devices Market, By Blood Storage Devices

• Refrigerators and Freezers
• Blood Bank Refrigerators

8. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

9. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

10. Competitive Landscape

• Key Players
• Market Share Analysis

11. Company Profiles

• Terumo Corporation
• Fresenius Kabi
• Haemonetics Corporation
• Grifols S.A.
• Macopharma
• Becton, Dickinson and Company (BD)
• Beckman Coulter, Inc. (Danaher Corporation)
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Immucor, Inc.
• Ortho Clinical Diagnostics
• Sartorius AG
• Siemens Healthineers AG
• Mediware Information Systems, Inc.
• Cerus Corporation
• LivaNova PLC
• MacoPharma SA
• Kawasumi Laboratories, Inc.
• China Biologic Products Holdings, Inc.

12. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

13. Appendix

• List of Abbreviations
• Sources and References